A comprehensive review of urologic complications in patients with diabetes

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  Arrellano Valdez, Fernando ^a   Urrutia Osorio, Marta ^a   Arroyo, Carlos ^b,c   Soto Vega, Elena ^a  

^a UNIVERSIDAD POPULAR AUTÓNOMA DEL ESTADO DE PUEBLA   (Mexico)

^b Section of Geriatrics   (Mexico)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Diabetes mellitus; Urologic diseases

Indexed keywords

EID: 84929322674     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-549     Document Type: Review

References (64)

1. Aizawa N, Homma Y, Igawa Y: Effects of mirabegron, a novel b3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.Eur Urol 2012, 62:1165–73.
2. American Diabetes Association: Diagnosis and classification of diabetes mellitus.Diabetes Care 2011,34(1):S62-S69.
3. Basu A, Ryder RE: New treatment options for erectile dysfunction in patients with diabetes mellitus.Drugs 2004,64(23):2667–2688.
4. Berger P, Deibl M, Halpern EJ, Lechleitner M, Bektic J, Horninger W, Fritsche G, Steiner H, Pelzer A, Bartsch G, Frauscher F: Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.Diabetologia 2005, 48:784–789.
5. Beshay E, Carrier S: Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model.Urology 2004, 64:1062.
6. Bittencourt JA, Tano T, Gajar SA, Resende AC, de Lemos NM, Damião R, Criddle DN, de Bem GF, de Moura RS: Relaxant effects of sildenafil on the human isolated bladder neck.Urology 2009,73(2):427–30.
7. Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC: Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic- associated erectile dysfunction.Biochem Biophys Res Commun 2001, 283:923–927.
8. Boulton AJ, Selam JL, Sweeney M, Ziegler D: Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus.Diabetologia 2001, 44:1296–1301.
9. Boyko EJ, Fihn SD, Scholes D, Chen CL, Normand EH, Yarbro P: Diabetes and the risk of acute urinary tract infection among postmenopausal women.Diabetes Care 2002, 25:1778–1783.
10. Brown JS, Nyberg LM, Kusek JW, Diokno AC, Foldspang FNH, Herzog AR, Hunskarr S, Milsom I, Nygaard I, Subak LL, Thom DH: Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on epidemiologic issues in urinary incontinence in women.Am J Obstet Gynecol 2003, 188:S77–88.
11. Brown JS, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma Y: Incontinence in women with impaired glucose tolerance: results of the Diabetes Prevention Program.J Urol 2004, 171:325–326.
12. Brownlee M: Biochemistry and molecular cell biology of diabetic complications.Nature 2001, 414:813–820.
13. Burchardt T, Burchardt M, Karden J, Buttyan R, Shabsigh A, de la Taille A, Ng PY, Anastasiadis AG, Shabsigh R: Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat.J Urol 2000, 164:1807–1811.
14. Caqueiro J, Casqueiro J, ALves C: Infections in patients with diabetes mellitus: a review of pathogenesis.Indian J Endocrinol Metab 2012,16(Suppl1):S27-S36.
15. Carson CC: Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients.Curr Urol Rep 2003, 4:488–496.
16. Cartledge JJ, Eardley I, Morrison JF: Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.BJU Int 2001, 87:402–407.
17. Changolkar AK, Hypolite JA, Disanto M, Oates PJ, Wein AJ, Chacko S: Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase.J Urol 2005, 173:309–313.
18. Chapple C, Nitti V, Khullar V, Wyndaele J, Herschom S, Van Kerrebroeck P, Beth M, Siddiqui E: Onset of action of the b3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder.World J Urol 2014. doi:10.1007/s00345–014–1244–2
19. Cheng JT, Yu BC, Tong YC: Changes of M3-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocininduced diabetic rats.Neurosci Lett 2007, 423:1–5.
20. Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW, Mills TM: Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.Nat Med 2001, 7:119–122.
21. Dalal S, Nicolle L, Marrs CF, Zhang L, Harding G, Foxman B: Long-term escherichia coli asymptomatic bacteriuria among women with diabetes mellitus.Clin Infect Dis 2009,49(4):491–497.
22. Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S: Diabetic bladder dysfunction: current translational knowledge.J Urol 2009, 182:S18-S26.
23. Dean RC, Lue TF: Physiology of penile erection and pathophysiology of erectile dysfunction.Urol Clin North Am 2005,32(4):379-v.
24. Deli G, Bonsbyak E, Pusch G, Komoly S, Feher G: Diabetic neuropathies:diagnosis and management.Neuroendocrinol 2013,98(4):267.280.
25. Doruk H, Akbay E, Çayan S, Akbay E, Bozlu M, Acar D: Effect of diabetes mellitus on female sexual function and risk factors.Arch Androl 2005,51(1):1–6.
26. Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K: Sexual dysfunction in women with type 1 diabetes: a controlled study.Diabetes Care 2002, 25:672–677.
27. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R: The role of insulin receptors and IGF-I receptors in cancer and other diseases.Arch Physiol Biochem 2008,114(1):23–37.
28. Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB, Kadesky KT, Kadesky MC, Clark AR, Roehrborn CG: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.J Urol 1998, 160:2041–2046.
29. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Collet TJ, Hoepelman AI: Risk factors for symptomatic urinary tract infection in women with diabetes.Diabetes Care 2000, 23:1737–1741.
30. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Hoekstra JB, Bouter PK, Braveboer B, Collet TJ, Jansz AR, Hoepelman AM: Asymptomatic bacteriuria can be considered a diabetic complication in women with diabetes mellitus.Adv Exp Med Biol 2000, 485:309–314.
31. Golbidi S, Laher I: Bladder dysfunction in diabetes mellitus.Front Pharmacol 2010, 1:136.
32. Grabe M, Bishop MC, Bjerklund-Johansen TE, Botto H, Cek M, Lobel B, Naber KG, Palou J, Tenke P, Wagenlehner F: Guidelines on urological infections.Eur Assoc Urol 2009. 1–108
33. Grant P, Jackson G, Baig I, Quin J: Erectile dysfunction in general medicine.Clin Med 2013,13(2):136–40.
34. Gray MA, Wang CC, Sacks MS, Yoshimura N, Chancellor M, Nagatomi J: Time dependent alterations of select genes in streptozotocin-induced diabetic rat bladder.Urology 2008, 71:1214–9.
35. Harding GK, Zhanel GG, Nicolle LE, Cheang M: Antimicrobial treatment in diabetic women with asymptomatic bacteriuria.N Engl J Med 2002, 347:1576–1583.
36. Heaton JP, Lording D, Liu SN, Litonjua AD, Guangwei L, Kim SC, Kim JJ, Zhi-Zhou S, Israr D, Niazi D, Rajatanavin R, Suyono S, Benard F, Casey R, Brock G, Belanger A: Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men.Int J Impot Res 2001, 13:317–321.
37. Huang SA, Lie JD: Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction.PT 2013, 38(7): 407:414–419.
38. Ikeda K, Wada Y, Foster HE, Wang Z, Weiss RM, Latifpour J: Experimental diabetes-induced regression of the rat prostate is associated with an increased expression of transforming growth factor-beta.J Urol 2000,164(1):180–185.
39. Jackson RA, Vittinghoff E, Kanaya AM, Resnick HE, Kritchevsky S, Miles T, Simonsick E, Brown JS: Aging and body composition.Obstet Gynecol 2004, 104:301–307.
40. Kammerer-Doak D: The treatment of female sexual dysfunction.Int Urogynecol Assoc 2012, 7:1.
41. Kebapci N, Yenilmez A, Efe B, Entok E, Demirustu C: Bladder dysfunction in type 2 diabetic patients.Neurourol Urodyn 2007,26(6):814–819.
42. Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF: Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study.J Urol 2003, 169:1437–1442.
43. Levine LA, Dimitriou RJ: Vacuum constriction and external erection devices in erectile dysfunction.Urol Clin North Am 2001, 28:335–341.
44. Liu JL: Does IGF-I stimulate pancreatic islet cell growth?Cell Biochem Biophys 2007,48(2–3):115–25.
45. Liu G, Daneshgari F: Temporal diabetes- and diuresis-induced remodeling of the urinary bladder in the rat.Am J Physiol Regul Integr Comp Physiol 2006, 291:R837.
46. McVary KT, Rathnau CH, McKenna KE: Sexual dysfunction in the diabetic BB/WOR rat: a role of central neuropathy.Am J Physiol 1997, 272:R259-R267.
47. Mcvary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donell RF, Foster HE Jr, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT: Update on AUA guideline on the management of benign prostatic hyperplasia.J Urol 2011,185(5):1793–803.
48. Morano S: Pathophysiology of diabetic sexual dysfunction.J Endocrinol Invest 2003,26(3 Suppl):65–9.
49. Neves D: Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction.Free Radic Res 2013,47(Suppl 1):49–69.
50. Owiredu WK, Amidu N, Alidu H, Sarpong C, Gyasi-Sarpong CK: Determinants of sexual dysfunction among clinically diagnosed diabetic patients.Reprod Biol Endocrinol 2011, 25:9:70.
51. Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G: Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs.Eur Urol 2001, 40:398–402.
52. Ronald A: The etiology of urinary tract infection: traditional and emerging pathogens.The Am J Med 2002, 113:14–19.
53. Rull JA, Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gómez-Pérez FJ, Olaiz G: Epidemiology of type 2 diabetes in Mexico.Arch Med Res 2005,36(3):188–196.
54. Satriano J: Kidney growth, hypertrophy and the unifying mechanism of diabetic complications.Amino Acids 2007, 33:331–339.
55. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, Polak J, Wang RZ, Ferguson K, Block C, Haas C: Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.Urology 1997,50(6):1016–1026.
56. Stapleton A: Urinary tract infections in patients with diabetes.Am J Med 2002,113(suppl 1A):80S-84S.
57. Sun P, Cameron A, Seftel A, Shabsigh R, Niederberger C, Guay A: Erectile dysfunction-an observable marker of diabetes mellitus? a large national epidemiological study.J Urol 2007, 117. 4:1588.
58. Torimoto K, Fraser MO, Hirao Y, De Groat WC, Chancellor MB, Yoshimura N: Urethral dysfunction in diabetic rats.J Urol 2004, 171:1959–64.
59. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E: Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.EMBO J 1986,5(10):2503–2512.
60. Vickers MA, Wright EA: Erectile dysfunction in the patient with diabetes mellitus.The Am J Managed Care 2004, 10:5–11.
61. Vikram A, Jena GB, Ramarao P: Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hiperplasia.Prostate 2010,1;70(1):79–89.
62. Wei-Chia L: The impact of diabetes on the lower urinary tract dysfunction.JTUA 2009, 20:155–61.
63. Yono M, Poursermail M, Takahashi W, Flanagan JF, Weiss RM, Latifpour J: Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes.Naunyn Schmiedebergs Arch Pharmacol 2005,372(3):251–255.
64. Yono M, Mane SM, Lin A, Weiss RM, Latifpour J: Differential effects of diabetes induced by streptozotocin and that develops spontaneously on prostate growth in Bio Breeding (BB) rats.Life Sci 2008,83(5–6):192–197.